Advertisement

Cerner and Lumeris Will Launch Offering to Reduce Complexities for Health Systems

By on

A new press release reports, “Cerner, a global leader in health care technology, and Lumeris, an award-winning health plan and value-based care managed services operator, today announced a 10-year relationship aimed at eliminating inefficiencies in the current health care system. Under the relationship, the parties will launch a new offering, Maestro Advantage, for value-based arrangements, including Medicare Advantage (MA) and provider-sponsored health plans (PSHPs). It combines Cerner and Lumeris technology and services to streamline redundant processes that burden the patient and provider, including lengthy claims processing and reimbursement cycles, and obstacles to sharing data and records. Maestro Advantage is designed to help health systems succeed with MA, and other value-based arrangements by improving the quality of outcomes and physician-patient encounters.”

John Doerr, Lumeris board member and chairman of Kleiner Perkins, commented, “The United States health care system’s transition to value-based care has been impeded by disjointed technology, cumbersome processes, misaligned incentives and inadequate management of clinical and financial outcomes… Maestro Advantage lowers the barriers to data transparency and sharing and empowers physicians and health systems. However, we know technology alone is not sufficient. Maestro Advantage is an innovative model with supporting processes and expertise to aid long-term success in value-based care arrangements. The combination of Cerner’s and Lumeris’ core competencies through Maestro Advantage is disruptive. Maestro Advantage is designed for patients to receive enhanced access to primary care and a level of service that was previously only delivered via expensive concierge medicine programs. Better outcomes and higher patient and provider satisfaction will provide our country with the health care system we deserve.”

Read more at Nasdaq.

Photo credit: Cerner

Leave a Reply